Compare CAVA Group Inc (CAVA) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CAVA Group Inc vs Recursion Pharmaceuticals Inc — how do they compare? CAVA Group Inc trades at $69.69 (market cap $8.45B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.75B). The key difference: CAVA Group Inc is far larger — about 4.8× Recursion Pharmaceuticals Inc's market cap, and CAVA Group Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CAVA | RXRX | |
|---|---|---|
Market Cap | $8.45B | $1.75B |
Sector | Consumer Cyclical | Health |
52-Week High | $97.39 | $6.79 |
52-Week Low | $43.59 | $2.84 |
Enterprise Value | $8.54B | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CAVA Group Inc
CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.
Read more on CAVA →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
